Safety Study of P28GST Treatment in Crohn's Disease Patients (ACROHNEM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02281916

Recruitment Status : Completed

First Posted : November 4, 2014

Last Update Posted : June 11, 2018

View this study on Beta.ClinicalTrials.gov

Sponsor:

Collaborators:

National Research Agency, France

Institut National de la Santé Et de la Recherche Médicale, France

Information provided by (Responsible Party):

University Hospital, Lille

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Completed
Actual Primary Completion Date :	February 2018
Actual Study Completion Date :	February 2018

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Foligne B, Ple C, Titecat M, Dendooven A, Pagny A, Daniel C, Singer E, Pottier M, Bertin B, Neut C, Deplanque D, Dubuquoy L, Desreumaux P, Capron M, Standaert A. Contribution of the Gut Microbiota in P28GST-Mediated Anti-Inflammatory Effects: Experimental and Clinical Insights. Cells. 2019 Jun 12;8(6):577. doi: 10.3390/cells8060577.

To Top